Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting …

G Dranoff, E Jaffee, A Lazenby… - Proceedings of the …, 1993 - National Acad Sciences
G Dranoff, E Jaffee, A Lazenby, P Golumbek, H Levitsky, K Brose, V Jackson, H Hamada…
Proceedings of the National Academy of Sciences, 1993National Acad Sciences
To compare the ability of different cytokines and other molecules to enhance the
immunogenicity of tumor cells, we generated 10 retroviruses encoding potential
immunomodulators and studied the vaccination properties of murine tumor cells transduced
by the viruses. Using a B16 melanoma model, in which irradiated tumor cells alone do not
stimulate significant anti-tumor immunity, we found that irradiated tumor cells expressing
murine granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulated potent, long …
To compare the ability of different cytokines and other molecules to enhance the immunogenicity of tumor cells, we generated 10 retroviruses encoding potential immunomodulators and studied the vaccination properties of murine tumor cells transduced by the viruses. Using a B16 melanoma model, in which irradiated tumor cells alone do not stimulate significant anti-tumor immunity, we found that irradiated tumor cells expressing murine granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulated potent, long-lasting, and specific anti-tumor immunity, requiring both CD4+ and CD8+ cells. Irradiated cells expressing interleukins 4 and 6 also stimulated detectable, but weaker, activity. In contrast to the B16 system, we found that in a number of other tumor models, the levels of anti-tumor immunity reported previously in cytokine gene transfer studies involving live, transduced cells could be achieved through the use of irradiated cells alone. Nevertheless, manipulation of the vaccine or challenge doses made it possible to demonstrate the activity of murine GM-CSF in those systems as well. Overall, our results have important implications for the clinical use of genetically modified tumor cells as therapeutic cancer vaccines.
National Acad Sciences